1-(2,3-Dichlorophenyl)piperazine Hydrochloride CAS 119532-26-2 Aripiprazole Intermediate Purity>99.0% (HPLC)

Inkcazelo emfutshane:

Igama: 1-(2,3-Dichlorophenyl)piperazine Hydrochloride

Izithethantonye: 2,3-DCPP HCl

CAS: 119532-26-2

Ubunyulu: >99.0% (HPLC)

Imbonakalo: I-White okanye i-Off-White Powder

Umbindi we-Aripiprazole (CAS: 129722-12-9)

E-Mail: alvin@ruifuchem.com


Iinkcukacha zeMveliso

Iimveliso ezinxulumeneyo

Iithegi zeMveliso

Inkcazo:

Iipropati zeMichiza:

Igama leMchiza 1-(2,3-Dichlorophenyl) piperazine Hydrochloride
Izithethantonye 2,3-DCPP HCl;I-1-(2,3-Dichlorophenyl) piperazine HCl;I-Aripiprazole EP Ukungcola B;I-Aripiprazole eNxulumene nayo iCompound C
Inombolo yeCAS 119532-26-2
Inombolo yeCAT RF-PI2268
Ubume beStokhwe Kwi-Stock, iMveliso yeMveliso ye-30 MT / inyanga
Ifomula yeemolekyuli C10H12Cl2N2·HCl
Ubunzima beMolekyuli 267.58
Indawo yokunyibilika 245.0 ~ 247.0℃
Ugcino & Novakalelo Hygroscopic.Amaqondo obushushu e-Ambient
Ukunyibilika emanzini Inyibilika emanzini
Uphawu Ruifu Chemical

Iinkcukacha:

Into Iinkcukacha
Imbonakalo Umgubo oMhlophe okanye oMhlophe
Ubunyulu / Indlela yokuHlalutya >99.0% (HPLC)
Ilahleko ekomisweni <0.50%
Intsalela kwi-Ignition <0.10%
Ukungacoceki Okukodwa <0.50%
Ukungcola ngokupheleleyo <1.00%
Iintsimbi ezinzima (njenge Pb) ≤20ppm
I-Infrared Spectrum Iyahambelana neSakhiwo
Umgangatho woVavanyo Umgangatho woShishino
Ukusetyenziswa Umbindi we-Aripiprazole (CAS: 129722-12-9)

Ukupakishwa kunye noGcino:

Iphakheji: Ibhotile, ingxowa yefoyile yeAluminiyam, 25kg/Igubu lekhadibhodi, okanye ngokwemfuno yomthengi

Imeko yoGcino:Hygroscopic.Gcina kude namanzi / ukufuma kunye nee-oxidizing agents.Gcina isikhongozeli sivalwe ngokuqinileyo kwaye usibeke kwindawo epholileyo, eyomileyo kwaye engenamoya.Gcina phantsi kwegesi engasebenziyo

Izinto eziluncedo:

1

FAQ:

Isicelo:

I-1-(2,3-Dichlorophenyl) i-piperazine Hydrochloride (CAS: 119532-26-2) yinto ebalulekileyo ephakathi kwe-Aripiprazole (CAS: 129722-12-9).I-Aripiprazole luhlobo olutsha lwezinto eziphuma kwi-quinoline ezine-lipid enyibilikayo, iimpawu zayo ze-pharmacological kukuba ayisiyiyo kuphela i-postsynaptic dopamine D 2 receptor antagonist, kodwa kunye ne-presynaptic dopamine D 2 receptor agonist, inokuvuyisa i-D 1, D 3, D 4 i-receptors;ineempembelelo ezimbini zokusebenzisa inxalenye okanye i-receptor antagonistic kwi-5-HT 1A i-receptor;inesenzo esichasayo ngokupheleleyo kwi-5-HT 2A receptor.Olu phawu lwahlukile kwisizukulwana sokuqala, kunye ne-atypical antipsychotics eyeyesibini isizukulwana sesibini seziyobisi, kwaye ke ibizwa ngokuba yi-dopamine system stabilizer okanye i-antipsychotic yesizukulwana sesithathu.Ekubeni ithengiswa kwimarike, isetyenziswa ikakhulu kwi-schizophrenia yeklinikhi, unyango lweengxaki ezichaphazelekayo kunye nezinye izifo zengqondo.Ngokutsho kweencwadi, i-aripiprazole ineempembelelo ezibalulekileyo kwi-schizophrenia iimpawu ezintle kunye ezimbi kunye nokuxhalaba, ukudakumba, umsebenzi wokuqonda, ngelixa ukhuseleko oluphezulu.Kwakhona kwaxelwa ukuba ichiza nako ukunyanga ezinye ukuphazamiseka kwengqondo, ezifana ukuphazamiseka kweemvakalelo manic episodes, senile dementia ezinxulumene nokuphazamiseka kwengqondo, ukuphazamiseka ixhala, ukuphazamiseka ukuziphatha abantwana, ukudakumba.Ngoku, iBristol-Myers Squibb kunye ne-Otsuka Pharmaceutical Company yabhengeza ukuba i-European Union yamnkele i-Abilify (aripiprazole) kunyango lwesicelo soluhlu lwe-schizophrenia.

Bhala umyalezo wakho apha kwaye uwuthumele kuthi